MedTrace Logo

BRUSH Sign: Radiolographic Marker of Cerebral Infarctus Prognosis

NCT03467269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2018-03-15

No results posted yet for this study

Summary

Today the treatment of ischemic stroke in acute phase is based on medicinal or endovascular revascularization. Cerebral MRI sequences help the diagnostic. This procedure uses deoxyhemoglobin as an endogenous tracer. This is also a scorer of cerebral ischemia and the increase lets visualized transcerebral veins in the suffering zone giving a brush aspect. Several studies show the interest of this sign and conclude that deoxyhemoglobin presence is a predictive factor of cerebral ischemia. The aim of the study is to evaluate this brush-sign and correlate it with the prognosis retrospectively.

Conditions

  • Cerebral Infarction

Interventions

DIAGNOSTIC_TEST

Brush sign

presence of a brush sign in MRI image in acute cerebral ischaemia

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Principal Investigators

  • ZUBER Mathieu, Professor · GHPSJ

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-24
Primary Completion
2017-04-01
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467269 on ClinicalTrials.gov